发明申请
- 专利标题： USE OF A PYRAZOLE DERIVATIVE FOR PREPARING MEDICINAL PRODUCTS THAT ARE USEFUL IN THE PREVENTION AND TREATMENT OF DYSLIPIDAEMIAS AND OF DISEASES RELATED TO DYSLIPIDAEMIAS AND/OR TO OBESITY
- 专利标题（中）： 使用吡唑衍生物制备有用于预防和治疗白斑病和与紫杉醇有关的疾病和/或肥胖的药物产品
-
申请号： US12463652申请日： 2009-05-11
-
公开(公告)号： US20090215755A1公开(公告)日： 2009-08-27
- 发明人: Michele Arnone , Jean Marc Herbert , Hassan Massoud Heshmati , Philip Janiak , Mohammed Bensaid
- 申请人： Michele Arnone , Jean Marc Herbert , Hassan Massoud Heshmati , Philip Janiak , Mohammed Bensaid
- 申请人地址： FR Paris
- 专利权人： SANOFI-AVENTIS
- 当前专利权人： SANOFI-AVENTIS
- 当前专利权人地址： FR Paris
- 优先权： FR0312553 20031024; FR0314763 20031215; FR0401193 20040205; FR0403252 20040326
- 主分类号： A61K31/454
- IPC分类号： A61K31/454 ; A61P3/04 ; A61P3/10 ; A61P9/00 ; A61K31/549
摘要：
Use of a pyrazole-derived compound that is an antagonist for cannabinoid CB1 receptors, alone or combined with another active principal, for preparing medicinal products that are useful in the prevention and treatment of dyslipidemias and of diseases related to dyslipidemias and/or to obesity, such as metabolic syndrome, cardiovascular risks and hepatic diseases.
信息查询
IPC分类:
